EPT Disclosure
June 21 2006 - 6:20AM
UK Regulatory
RNS Number:9318E
GoldmanSachs International
21 June 2006
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Goldman Sachs International
Company dealt in CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
Class of relevant security to which the Ordinary Shares
dealings being disclosed relate (Note 1)
Date of dealing 20 June 2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3)
27200 13.09 GBP 13.09 GBP
Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3)
363235 13.11 GBP 13.09 GBP
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
e.g. CFD
CFD Long 50000 13.11 GBP
CFD Long 300 13.11 GBP
CFD Long 33605 13.11 GBP
CFD Long 16182 13.11 GBP
CFD Long 22403 13.11 GBP
CFD Long 10788 13.11 GBP
CFD Long 34500 13.11 GBP
CFD Long 5500 13.11 GBP
CFD Long 39000 13.11 GBP
CFD Long 13500 13.11 GBP
CFD Long 3000 13.11 GBP
CFD Long 9109 13.11 GBP
CFD Long 2950 13.11 GBP
CFD Long 25863 13.11 GBP
CFD Long 9088 13.11 GBP
CFD Long 4450 13.11 GBP
CFD Long 16766 13.11 GBP
CFD Long 7401 13.11 GBP
CFD Long 18500 13.11 GBP
CFD Long 6500 13.11 GBP
CFD Long 2130 13.11 GBP
CFD Long 4500 13.11 GBP
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities to Exercise Type, e.g. Expiry Option money
purchasing, which the option relates price American, date paid/received per
e.g. call varying etc. (Note 5) European unit (Note 3)
option etc.
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
Date of disclosure 21 June 2006
Contact name Peter Highton
Telephone number +44-207-774-1935
Name of offeree/offeror with which connected Astrazeneca
Nature of connection (Note 6) Advisor
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSEWFSFSMSEFM
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
